Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNTY
2951
DELISTED
Guaranty Bancshares
GNTY
| $619K | ﹤0.01% |
22,855
+984
| +4% | +$24.8K |
|
2952
Universal Electronics
UEIC
$58M
| $619K | ﹤0.01% |
64,333
-24,243
| -27% | -$224K |
|
2953
Asure Software
ASUR
$240M
| $616K | ﹤0.01% |
+50,675
| New | +$675K |
|
2954
Ocugen
OCGN
$427M
| $616K | ﹤0.01% |
1,134,020
-384,808
| -25% | -$247K |
|
|
LPTV
2955
DELISTED
Loop Media, Inc.
LPTV
| $614K | ﹤0.01% |
256,753
+84,180
| +49% | +$329K |
|
2956
Universal Technical Institute
UTI
$2.21B
| $613K | ﹤0.01% |
88,641
-1,400
| -2% | -$9.43K |
|
2957
Genelux
GNLX
$137M
| $612K | ﹤0.01% |
18,700
+3,524
| +23% | +$99.1K |
|
2958
First Business Financial Services
FBIZ
$562M
| $610K | ﹤0.01% |
20,683
-305
| -1% | -$8.65K |
|
|
REFI
2959
Chicago Atlantic Real Estate Finance
REFI
$249M
| $610K | ﹤0.01% |
40,252
+27,826
| +224% | +$404K |
|
2960
Full House Resorts
FLL
$79.4M
| $605K | ﹤0.01% |
90,352
+377
| +0.4% | +$2.59K |
|
2961
Fidelity D&D Bancorp
FDBC
$305M
| $604K | ﹤0.01% |
+12,439
| New | +$541K |
|
2962
Nathan's Famous
NATH
$403M
| $603K | ﹤0.01% |
+7,682
| New | +$574K |
|
2963
Donegal Group Class A
DGICA
$732M
| $601K | ﹤0.01% |
41,663
-199
| -0.5% | -$2.94K |
|
2964
Wave Life Sciences
WVE
$1.11B
| $601K | ﹤0.01% |
165,138
+135,163
| +451% | +$546K |
|
2965
Immersion
IMMR
$246M
| $599K | ﹤0.01% |
84,660
+71,559
| +546% | +$530K |
|
2966
Zura Bio
ZURA
$526M
| $598K | ﹤0.01% |
+72,925
| New | +$586K |
|
2967
Northrim BanCorp
NRIM
$586M
| $597K | ﹤0.01% |
+60,736
| New | +$610K |
|
|
GTHX
2968
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $597K | ﹤0.01% |
239,609
+35,245
| +17% | +$96.3K |
|
2969
Red Robin
RRGB
$144M
| $595K | ﹤0.01% |
+42,999
| New | +$577K |
|
|
AKTS
2970
DELISTED
Akoustis Technologies Inc
AKTS
| $591K | ﹤0.01% |
185,991
+6,917
| +4% | +$21.2K |
|
2971
D-Wave Quantum Inc. Common Stock
QBTS
$6.66B
| $589K | ﹤0.01% |
281,876
+77,391
| +38% | +$85.2K |
|
2972
Norwood Financial Corp
NWFL
$367M
| $589K | ﹤0.01% |
+19,937
| New | +$546K |
|
|
KALV
2973
DELISTED
KalVista Pharmaceuticals
KALV
| $586K | ﹤0.01% |
65,154
+1,287
| +2% | +$11.9K |
|
2974
Orchestra BioMed
OBIO
$239M
| $586K | ﹤0.01% |
83,647
+17,052
| +26% | +$259K |
|
2975
Pure Cycle
PCYO
$258M
| $585K | ﹤0.01% |
53,159
+215
| +0.4% | +$2.13K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.